Kopran Ltd. (KOPRAN) 52 Week High Streak Extends for Second Straight Session
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Kopran Ltd. has now traded within 2% of its 52-week high for its second straight session, with the stock moving 4.93% across the streak. The latest trading range kept KOPRAN close to its yearly peak, but the latest Univest figures confirm the price pattern only; they do not establish a company-specific catalyst for the repeated near-high move.
As of 21 September 2026 at 10:18 AM IST, Kopran Ltd. was trading at Rs 281.85 versus the previous close of Rs 277.75. The stock opened at Rs 277.9, touched a day low of Rs 276.85 and a high of Rs 286.5, while turnover stood at Rs 1.36 crore and market capitalisation at Rs 1,342.26 crore. For readers, the repeated-high pattern matters more than a single-session jump because it shows the stock has stayed near its one-year high across multiple trading sessions.
Kopran Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 281.85 |
| Previous Close | Rs 277.75 |
| Today's Move | +Rs 4.1 (+1.48%) |
| Open | Rs 277.9 |
| High | Rs 286.5 |
| Low | Rs 276.85 |
| Turnover | Rs 1.36 crore |
| Market Capitalisation | Rs 1,342.26 crore |
Kopran Ltd. (KOPRAN) traded at Rs 281.85 versus the previous close of Rs 277.75, a rise of 1.48%. The stock opened at Rs 277.9, reached a high of Rs 286.5 and touched a low of Rs 276.85.
Kopran Ltd. share price today was firm in early trade, with KOPRAN last traded at Rs 281.85, up Rs 4.10 or 1.48% from the previous close of Rs 277.75. The move came after an opening print of Rs 277.9 and a trading band of Rs 276.85 to Rs 286.5, which placed the latest price in the upper half of the day’s range. That keeps the Kopran Ltd. share price aligned with the broader 52 Week High Streak narrative rather than a one-off move.
The key point for stock news readers is that Kopran Ltd. share price remains close to its one-year high while turnover stands at Rs 1.36 crore and market cap at Rs 1,342.26 crore. In other words, the market is still valuing the stock near its recent peak area, and the streak framing is more useful than the single-day change alone. The latest KOPRAN NSE move also fits the pattern seen across the previous session, when the stock first moved into this near-high zone.
What the Repeated 52-Week Highs Show
The repeated near-high pattern suggests that Kopran Ltd. has remained in the same price zone for more than one session, which is the defining feature of a 52 Week High Streak. The stock has now traded within 2% of its 52-week high for a second straight session, and the cumulative move across that streak is 4.93%. That is the core reading investors should track, because it captures the full streak rather than just today’s fluctuation.
What the repeated 52-week highs show is a stock that has stayed close to its yearly peak without breaking away from that zone in a single day. The latest data also confirm that the current 52-week high sits above the prior one, but a previous 52-week high figure has not been provided here, so the comparison can only be made in directional terms. For searches around Kopran Ltd. New One Year High or Kopran Ltd. Back To Back 52 Week Highs, the factual takeaway is simple: the pattern is intact, but the reason for it is not confirmed by the price data alone.
Kopran Ltd. (KOPRAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,342.26 crore |
| P/E Ratio | 53.72x |
| P/B Ratio | 2.5x |
| ROE | 4.92% |
| ROCE | 6.65% |
| EPS | Rs 5.17 |
| Book Value Per Share | Rs 110.98 |
| Dividend Yield | 1.08% |
Kopran Ltd. (KOPRAN) fundamental metrics show P/E 53.72x, P/B 2.5x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.
Kopran Ltd. has a market capitalisation of Rs 1342.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.72x, P/B at 2.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.17, book value per share of Rs 110.98, dividend yield of 1.08%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.72x |
| Benchmark Median P/E | 28.19x |
| Benchmark Average P/E | 40.34x |
| Benchmark P/E Range | 0x to 683.5x |
| Company P/B Ratio | 2.5x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 4.92% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 6.65% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 1,342.26 crore |
| Benchmark Median Market Cap | Rs 677.56 crore |
Kopran Ltd. (KOPRAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kopran Ltd. (KOPRAN) has a P/E ratio of 53.72x, which is above the benchmark median of 28.19x, a difference of +90.56%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kopran Ltd. (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.7%, a difference of -57.95%. Kopran Ltd. (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.61%, a difference of -51.14%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Fermenta Biotech Ltd. | FERMENTA | 1,400.18 | 23.15 | 3.39 | 18.36 | 21.99 |
| Amrutanjan Health Care Ltd. | AMRUTANJAN | 1,427.17 | 26.44 | 3.8 | 16.62 | 22.46 |
| ANLON HEALTHCARE LIMITED | AHCL | 1,219.3 | 42.76 | 4.18 | 18.73 | 21.98 |
| Lincoln Pharmaceuticals Ltd. | LINCOLN | 1,214.6 | 12.59 | 1.53 | 13.02 | 17.55 |
| Jagsonpal Pharmaceuticals Ltd. | JAGSNPHARM | 1,503.83 | 33.07 | 6.53 | 18.19 | 22.69 |
Kopran Ltd. (KOPRAN) has a P/E ratio of 53.72x compared with the displayed peer median of 26.44x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.92% compares with a peer median of 18.19% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 21.99%, providing a capital-efficiency comparison. Kopran Ltd. (KOPRAN) has a market capitalisation of Rs 1,342.26 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Kopran Ltd.
- Kopran Ltd. is trading within 2% of its 52-week high for the second straight session.
- The cumulative move across the streak stands at 4.93%.
- The current price is Rs 281.85, keeping KOPRAN near its yearly peak area.
- Valuation at 53.72 times earnings is above the industry median in the Healthcare set.
- Return ratios remain below the peer-group medians for ROE and ROCE.
About Kopran Ltd.
Kopran Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listed equity story is being tracked through its share price, market capitalisation, earnings multiples and return ratios rather than through a single-day move. For readers following Kopran Ltd. share price today, the key context is that the stock is moving near its yearly high while remaining a mid-sized listed healthcare name.
The stock news angle is therefore a combination of price behaviour and business metrics. Kopran Ltd. stock performance is being watched because the market is still keeping the share close to its 52-week high, while the company’s valuation and profitability ratios provide a separate lens for assessment. That is why searches such as Kopran Ltd. company news, Kopran Ltd. market cap and Kopran Ltd. stock analysis continue to matter.
Track Kopran Ltd. on Univest
Follow Kopran Ltd. on Univest for the latest share price update, stock news and market cap view in one place. The stock page brings together Kopran Ltd. NSE and Kopran Ltd. BSE context, along with company financials and comparison data that help readers track the 52 Week High Streak over time.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What does Kopran Ltd. 52 Week High Streak mean?
Ans. It means Kopran Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the stock has done so for a second straight session, which is why the streak framing matters more than a single-day move.
How many sessions has Kopran Ltd. stayed near its 52-week high?
Ans. Kopran Ltd. has stayed within 2% of its 52-week high for two consecutive sessions. The latest pattern confirms a repeated near-high trade, not necessarily a new all-time or record high.
What is the cumulative move across the Kopran Ltd. streak?
Ans. The cumulative move across the streak is 4.93%. That figure captures the full two-session pattern and is the key number readers should use when tracking the Kopran Ltd. 52 Week High Streak.
Is Kopran Ltd. at a new one-year high today?
Ans. The price is trading near the one-year high area, but this article does not claim a fresh break above that level. The important point is that Kopran Ltd. remains within 2% of its 52-week high across consecutive sessions.
What was Kopran Ltd. trading at today?
Ans. Kopran Ltd. was last trading at Rs 281.85, compared with the previous close of Rs 277.75. The stock opened at Rs 277.9 and moved between Rs 276.85 and Rs 286.5 during the trading window.
How does Kopran Ltd. compare with peers in Healthcare?
Ans. Compared with peers such as Fermenta Biotech, Amrutanjan Health Care and Lincoln Pharmaceuticals, Kopran Ltd. has a higher P/E and lower ROE and ROCE. That makes valuation and operating efficiency the main comparison points for readers.
What should investors watch next in Kopran Ltd.?
Ans. Investors should watch whether Kopran Ltd. keeps trading near its yearly high and whether the current valuation is supported by future performance. The near-high streak is the immediate market pattern; the business ratios and peer comparison provide the longer-term context.
Track Kopran Ltd. (KOPRAN) Share Price on Univest
Use Kopran Ltd. (KOPRAN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
